Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Philipp Kron Michael Linecker Bostjan Humar Jean-Marie Lehn Pierre-Alain Clavien |
| Publication date | October 19, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |